Contrasting QT Imaging (NASDAQ:QTI) and BioSig Technologies (NASDAQ:BSGM)

BioSig Technologies (NASDAQ:BSGM) and QT Imaging (NASDAQ:QTI) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, earnings, risk, profitability, analyst recommendations, institutional ownership and valuation.

Volatility and Risk

BioSig Technologies has a beta of 0.55, suggesting that its share price is 45% less volatile than the S&P 500. Comparatively, QT Imaging has a beta of -0.2, suggesting that its share price is 120% less volatile than the S&P 500.

Institutional & Insider Ownership

7.2% of BioSig Technologies shares are owned by institutional investors. Comparatively, 24.2% of QT Imaging shares are owned by institutional investors. 17.0% of BioSig Technologies shares are owned by company insiders. Comparatively, 75.4% of QT Imaging shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Profitability

This table compares BioSig Technologies and QT Imaging’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
BioSig Technologies	-44,832.50%	N/A	-776.49%
QT Imaging	N/A	N/A	-65.94%

Analyst Recommendations

This is a breakdown of current recommendations and price targets for BioSig Technologies and QT Imaging, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BioSig Technologies	0	0	1	0	3.00
QT Imaging	0	0	0	0	0.00

BioSig Technologies presently has a consensus price target of $2.75, suggesting a potential upside of 202.60%. Given BioSig Technologies’ stronger consensus rating and higher possible upside, equities research analysts plainly believe BioSig Technologies is more favorable than QT Imaging.

Valuation & Earnings

This table compares BioSig Technologies and QT Imaging”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioSig Technologies	$20,000.00	783.39	-$29.04 million	N/A	N/A
QT Imaging	$4.00 million	2.10	-$4.03 million	N/A	N/A

QT Imaging has higher revenue and earnings than BioSig Technologies.

Summary

QT Imaging beats BioSig Technologies on 6 of the 11 factors compared between the two stocks.

About BioSig Technologies

BioSig Technologies, Inc., together with its subsidiaries, a medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

About QT Imaging

QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems for detection, diagnosis, monitoring, and treatment of diseases. The company offers QT Ultrasound Breast Scanner, an ultrasonic imaging system that provides reflection-mode and transmission-mode images of a patient’s breast. QT Imaging Holdings, Inc. was founded in 2011 and is based in Novato, California.